Compounded Tirzepatide: How It Works, What It Costs, and Whether It’s Right for You

Quick answer: Tirzepatide is a once-weekly injectable medication that mimics two hormones — GLP-1 and GIP — to reduce appetite and improve blood sugar control. It’s the active ingredient in Mounjaro and Zepbound. FaroRx offers compounded tirzepatide starting at $249/month after an online visit with a licensed U.S. provider.

If you’ve researched GLP-1 medications, you’ve likely run into tirzepatide as “the stronger one.” That reputation comes from real biology — but it’s worth understanding what’s actually going on before deciding if it’s the right fit for you.

What makes tirzepatide different from semaglutide

Semaglutide mimics one hormone: GLP-1. Tirzepatide mimics two: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). Both hormones are released naturally after eating and play a role in appetite regulation, digestion, and blood sugar control. By acting on both pathways at once, tirzepatide tends to produce a stronger effect on appetite suppression and blood sugar stability for many patients — which is why it’s often associated with greater average weight loss in clinical research.

That doesn’t make it automatically “better” for everyone. Response to any GLP-1 medication varies by individual, and your provider will help determine which option fits your health profile.

How compounded tirzepatide works with FaroRx

1. Take the health quiz — about 3 minutes, covering your weight-loss goals and health history.
2. Meet your provider online — a licensed U.S. provider reviews your intake and builds a titration plan if tirzepatide is clinically appropriate.
3. Get it shipped monthly — your medication and injection supplies arrive free and discreetly, with dose adjustments and care team messaging along the way.

Pricing: $249/month, with quarterly ($669) and six-month ($1,199) options.

Compounded vs. brand-name tirzepatide

Brand-name tirzepatide (Mounjaro, Zepbound) is manufactured by Eli Lilly and FDA-approved as a finished product. Compounded tirzepatide is prepared by a licensed U.S. pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act, using the same active ingredient.

Important: Compounded medications are not FDA-approved and are not generic versions of, or equivalent to, any branded medication. The FDA does not review compounded formulations for safety, effectiveness, or manufacturing quality. Compounding exists as a separate, regulated pathway — often used to address supply shortages or offer a more accessible price point — and it’s prescribed only when clinically appropriate following an online visit.

What results typically look like

Average results across GLP-1/GIP therapy over 12 months fall in the 15–20% body weight range, with some patients on tirzepatide seeing results toward the higher end of that range. As always, this is an average — not a promise — and depends on dose, consistency, diet, and individual biology.

Common side effects

Like other GLP-1/GIP medications, the most common side effects are gastrointestinal: nausea, reduced appetite, occasional constipation or diarrhea, especially during the first few weeks as your body adjusts. Providers typically start at a low dose and titrate up gradually to minimize discomfort.

Frequently Asked Questions

Is tirzepatide stronger than semaglutide? Tirzepatide acts on two hormone pathways (GLP-1 and GIP) instead of one, which is associated with greater average weight loss in clinical studies. However, individual response varies, and the right choice depends on your health history and how your body responds — a decision best made with your provider.

How is compounded tirzepatide different from Zepbound or Mounjaro? Zepbound and Mounjaro are FDA-approved brand-name products. Compounded tirzepatide uses the same active ingredient but is prepared by a licensed compounding pharmacy under Section 503A rather than reviewed by the FDA as a finished product.

How often do I inject tirzepatide? Once per week, at a dose set and adjusted by your provider over time.

Do I need insurance to get tirzepatide through FaroRx? No — FaroRx’s model doesn’t require insurance. You pay a flat monthly membership price for your medication and provider oversight.

How fast will I see results? Most patients notice reduced appetite within the first few weeks, with meaningful weight change typically building over the following months as your dose is titrated.

Is it right for you?

If you’ve plateaued with diet and exercise alone, or want stronger appetite and blood sugar support than you’ve gotten from semaglutide, compounded tirzepatide may be worth discussing with a provider.

See if you qualify for compounded tirzepatide →

Compounded medications are not FDA-approved and are not generic versions of, or equivalent to, any branded medication. They are prescribed only when clinically appropriate following an online medical visit with a licensed provider. Individual results vary.